Citadel Advisors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Citadel Advisors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-15,500	Closed	-$828K	–	8058
2016 Q1	$828K	Buy	15,500 +3,700	+31%	+$273K	﹤0.01%	3706
2015 Q4	$1.33M	Sell	11,800 -11,200	-49%	-$1.23M	﹤0.01%	3236
2015 Q3	$2.71M	Sell	23,000 -10,900	-32%	-$1.42M	﹤0.01%	2583
2015 Q2	$2.63M	Sell	33,900 -8,400	-20%	-$551K	﹤0.01%	2746
2015 Q1	$2.45M	Buy	42,300 +5,900	+16%	+$250K	﹤0.01%	2818
2014 Q4	$1.17M	Buy	36,400 +19,100	+110%	+$573K	﹤0.01%	3569
2014 Q3	$423K	Buy	+17,300	New	+$351K	﹤0.01%	4841
2014 Q2	–	Sell	-3,700	Closed	-$74K	–	8876
2014 Q1	$74K	Buy	+3,700	New	+$71.7K	﹤0.01%	6455

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Citadel Advisors's ANAC Position: Q2 2016 in Review

Citadel Advisors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 313,988 shares — an estimated $16.8M sold.

Citadel Advisors first reported a position in ANAC in Q1 2014 and held it in 8 quarters. The position peaked at $81M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Citadel Advisors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Citadel Advisors sold 313,988 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $16.8M.
Citadel Advisors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 8 quarters.
Citadel Advisors's ANACOR PHARMACEUTICALS INC COM position peaked at $81M in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Citadel Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.